Innoviva (INVA) Times Interest Earned (2010 - 2026)
Innoviva posted quarterly Times Interest Earned of $7.02 for Q1 2026, down 20.2% year-on-year from $8.79 in Q1 2025, and down 18.52% on a QoQ basis from $8.61 in Q3 2025.
Innoviva (INVA) has 17 years of Times Interest Earned data on file, last reported at $7.02 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned fell 20.2% year-over-year to $7.02; the trailing twelve-month figure through Mar 2026 stood at $7.63 (down 3.36% YoY), and the FY2025 full-year result was $9.81, up 30.52% from the prior year.
- Times Interest Earned for Q1 2026 stood at $7.02, down from $8.61 in the prior quarter.
- Across five years, Times Interest Earned topped out at $19.55 in Q3 2023 and bottomed at -$2.92 in Q1 2022.
- The 5-year median for Times Interest Earned is $7.02 (2026), against an average of $4.57.
- The widest annual swing landed in 2022, when Times Interest Earned plunged 151.78%; it then surged 1992672.48% in 2023.
- A 5-year view of Times Interest Earned shows it stood at $0.0 in 2022, then soared by 1992672.48% to $19.55 in 2023, then sank by 61.92% to $7.45 in 2024, then grew by 15.67% to $8.61 in 2025, then declined by 18.52% to $7.02 in 2026.
- The last three Times Interest Earned figures came in at $7.02 (Q1 2026), $8.61 (Q3 2025), and $10.45 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 7.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.02 |
| Sep 30, 2025 | 8.61 |
| Jun 30, 2025 | 10.45 |
| Mar 31, 2025 | 8.79 |
| Sep 30, 2024 | 7.45 |
| Jun 30, 2024 | 9.43 |
| Mar 31, 2024 | -1.75 |
| Sep 30, 2023 | 19.55 |
| Jun 30, 2023 | -2.20 |
| Mar 31, 2023 | -2.56 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | -2.52 |
| Mar 31, 2022 | -2.92 |
| Sep 30, 2021 | 19.74 |
| Jun 30, 2021 | 20.35 |
| Mar 31, 2021 | -1.16 |
| Dec 31, 2020 | -1.39 |
| Sep 30, 2020 | 18.34 |
| Jun 30, 2020 | 16.62 |
| Mar 31, 2020 | 16.85 |
| Dec 31, 2019 | 15.70 |
| Sep 30, 2019 | 12.95 |
| Jun 30, 2019 | 12.82 |
| Mar 31, 2019 | 11.30 |
| Dec 31, 2018 | 16.86 |
| Sep 30, 2018 | 11.01 |
| Jun 30, 2018 | 9.68 |
| Mar 31, 2018 | 5.31 |
| Dec 31, 2017 | 1.82 |
| Sep 30, 2017 | 6.28 |
| Jun 30, 2017 | 3.92 |
| Mar 31, 2017 | 2.30 |
| Dec 31, 2016 | 2.90 |
| Sep 30, 2016 | 2.13 |
| Jun 30, 2016 | 1.97 |
| Mar 31, 2016 | 1.33 |
| Dec 31, 2015 | 1.33 |
| Sep 30, 2015 | 0.65 |
| Jun 30, 2015 | 0.39 |
| Mar 31, 2015 | 0.06 |
| Dec 31, 2014 | 0.01 |
| Sep 30, 2014 | -0.77 |
| Jun 30, 2014 | -0.95 |
| Mar 31, 2014 | -8.96 |
| Dec 31, 2013 | -4.40 |
| Sep 30, 2013 | -4.05 |
| Jun 30, 2013 | -2.28 |
| Mar 31, 2013 | -12.20 |
| Dec 31, 2012 | -28.08 |
| Sep 30, 2012 | -22.23 |
| Jun 30, 2012 | -23.79 |
| Mar 31, 2012 | 57.28 |
| Dec 31, 2011 | -23.67 |
| Sep 30, 2011 | -19.40 |
| Jun 30, 2011 | -15.71 |
| Mar 31, 2011 | -14.11 |
| Dec 31, 2010 | -11.90 |
| Sep 30, 2010 | -13.12 |
| Jun 30, 2010 | -12.89 |